2007年我院门诊口服抗糖尿病药应用分析

Analysis of Outpatient Use of Hypoglycemic Agents in Our Hospital in 2007

目的:对我院门诊口服抗糖尿病药的应用情况进行分析评估,为临床合理用药提供参考依据。方法:对我院2007年口服抗糖尿病药的用药频度(DDDs)进行统计、分析。结果:葡萄糖苷酶抑制剂药物用药频度较高,占28.39%,其次是磺酰脲类,占25.45%。结论:葡萄糖苷酶抑制剂是新型口服抗糖尿病药,用于降低餐后血糖,其降糖效果显著、安全,是目前糖尿病患者的首选药物。

OBJECTIVE： To evaluate the outpatient use of hypoglycemic agents in our hospital for reference of clinical rational use of this kind of drugs. METHODS： The DDDs of the oral hypoglycenic agents in our hospital in 2007 were analyzed statistically. RESULTS： Leading the list of DDDs was glucosidase inhibitor, which accounted for 28.39% of the total, followed by sulfonylureas which accounted for 25.45 % . CONCLUSION： The glucosidase inhibitor, a new type oral hypoglycemic agent used for lowering postprandial blood sugar level showed remarkable efficacy and safety, so it is currently the first choice for patients with diabetes.